Free Access to TSR Screeners - Sign Up for Your Nightly Pass
Birds's Eye
Technicals
MovingAverage
Candlestick
PivotPoint
Fin Statements
Beta&Vols
Tech ChartsFundamental Analysis of Health X Platform Limited - Growth / Value Index
HEALTHX - Valuation Highlights
Valuation Analysis
Tsr Value Index - Poor Score of 25.00
Very Expensive - Price to Intrinsic Value of 3.18
Book Value in last 3 years is trending down
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ | Screener/ About |
|---|---|---|---|---|---|
| Price to Earning | -46.28 | 694.46 | 8310.22 % | ||
| Price to Book | 1.79 | 1.28 | 11.07 % | 0 | |
| Price to Sales | 0.637 | 0.621 | -10.52 % | ||
| Enterprise Value to EBITDA Multiple | 163.24 | 4117.72 % |
HEALTHX - Profitability Highlights
Profitability Analysis
Net profit has jumped from negative to positive
Piotroski F Score - Stable Value of 4.0
Steady Growth in EPS for last four quarters
Tsr Profitability Index - Poor Score of 32.14
Very Low Dividend Yield of 0 %
In the last three years, the company has given poor Net Margin
In the last three years, the company has given poor Returns on Equity
In the last three years, the company has given poor Returns on Assets
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ | Screener/ About |
|---|---|---|---|---|---|
| Return On Equity | -4.97 | 0.184 | 101.35 % | 0 | |
| Return On Asset | -3.38 | 0.126 | 101.35 % | 0 | |
| Net Profit Margin | -1.38 | 0.089 | 101.09 % | 0.568 | |
| Operating Profit Margin | -4.89 | -4.51 | 19.29 % | -2.30 | |
| EBITDA Margin | -1.10 | 0.381 | 102.26 % | 1.12 |
Highlights
| Market Cap | 9374.55 M |
| Enterprise Value | 9374.55 M |
| Price/Book TTM | 1.79 |
| Outstanding Share | 31810.50 K |
| Float/ Outstanding Share | 19.60% |
| Dividend Yield | 0 % |
Share Holding
Guru Numbers
| Price/Graham No | 0 |
| Peter Lynch Ratio | 0 |
| Piotroski F Score | 4.00 |
| Altman Z Score | 4.07 |
| Sloan Ratio | -0.103 |
| Peter Lynch Fair Value | 0 |
HEALTHX - Growth Highlights
Growth Analysis
Short term positive trend in total sale and net profit
Quarterly sales in last 5 years is trending up
Company's Total Assets is Decreasing for last 3 years
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 1467.69 (Cr) | 18.75 % | 19.55 % |
| Gross Profit | 26.53 (Cr) | 100.00 % | % |
| EBITDA | -16.09 (Cr) | 102.69 % | 147.26 % |
| Net Profit | -20.19 (Cr) | 101.29 % | 122.74 % |
| EPS | -6.37 | 101.29 % | NA |
HEALTHX - Stability Highlights
Stability Analysis
Tsr Stability Index - Good Score of 77.50
Altman Z Score of 4.07 suggests good Stability
Company is Debt Free
Interest Coverage of -2.03
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ | Screener/ About |
|---|---|---|---|---|
| Debt to Equity Ratio | 0 | 0 % | 0 | |
| Cash Ratio | 0.213 | 50.72 % | ||
| Quick Ratio | 4.17 | -47.40 % | 0 | |
| Shareholders Equity | 68.49 | -0.380 % | ||
| Debt to EBITDA | 0 | 0 % |
Historical Valuation Ratios of Health X Platform Limited
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Health X Platform Limited
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Health X Platform Limited
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Health X Platform Limited
Historical Solvency Ratios
Loading ...